Release Date: 28/07/17 09:58 Summary: Hawsons Prefeasibility Study Results Price Sensitive: Yes Download Document 1003.76KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%